STAT3 and congenital rubella syndrome: Our in vivo findings show that STAT3-targeting provides a significant disease control in mice with CRS, unexpectedly highlighting how blocking a single member of the NF-κB/STAT3 loop is sufficient to halt pathological inflammation.